Leaders Series S6 EP 5: AI in Drug Discovery: Hype vs Reality | GCS Leaders Series S6 E5 with Aylin Cakiroglu

Leaders Series S6 EP 5: AI in Drug Discovery: Hype vs Reality | GCS Leaders Series S6 E5 with Aylin Cakiroglu

Is AI truly transforming drug discovery or are we still in the hype phase? In this episode of the GCS Leaders Series Podcast, host David Bloxham (CEO, GCS) sits down with Aylin Cakiroglu, Independent Consultant in AI for Drug Discovery, to explore how AI is reshaping pharma and biotech. From large language models in biology to the real limitations of data, this episode dives deep into the true impact of AI in life sciences.

Leader Series

GCS Leader Series

First Name^*

Last Name^*

Job Title^*

Email^*

Mobile Phone

Password^*

At least 8 characters, 1 uppercase, 1 lowercase and 1 special character or number

Confirm Password^*

ATTACH CV ^*

Your file must be a doc, docx or pdf. No larger than 5MB.

Synopsis (optional)